As I mentioned in my opening remarks, there are a number of measures. We have certain levers that we can exercise under the Food and Drugs Act, and we are using our full authorities there to do what we can to mitigate this issue. However, the provinces and territories also have their jurisdictions with regard to these products, including marketing, advertising, and accessibility. That is why we're working very closely with them to come up with a suite of measure that will fully address this problem.
On April 30th, 2018. See this statement in context.